Detection of influenza A and B with the Alere™ i Influenza A & B: A novel isothermal nucleic acid amplification assay

Influenza and other Respiratory Viruses

Volumn 9, Issue 3, 2015, Pages 151-154

  Hazelton, Briony ^a,b   Gray, Timothy ^a,b   Ho, Jennifer ^a,b   Ratnamohan, V Mala ^a   Dwyer, Dominic E ^a,b,c   Kok, Jen ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Influenza; Isothermal nucleic acid amplification; Rapid diagnostic test(s); Sensitivity; Specificity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; INFLUENZA A; INFLUENZA A AND B RAPID TEST; INFLUENZA A RAPID TEST; INFLUENZA B; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSPORT MEDIUM; AUSTRALIA; FEMALE; GENETICS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MOLECULAR DIAGNOSIS; POINT OF CARE SYSTEM; SEASON; SENSITIVITY AND SPECIFICITY; STANDARD; YOUNG ADULT;

ADULT; AUSTRALIA; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEASONS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84928213199     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12303     Document Type: Article

References (24)

1. Petrozzino JJ, Smith C, Atkinson MJ. Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosis. J Emerg Med 2010; 39:476-490.
2. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003; 112:363-367.
3. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012; 156:500-511.
4. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1003-1032.
5. Kok J, Blyth CC, Foo H et al. Comparison of a rapid antigen test with nucleic acid testing during co-circulation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J Clin Microbiol 2010; 48:290-291.
6. Nie S, Roth RB, Stiles J et al. Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol 2014; 52:3339-3344.
7. ™ i Influenza A&B isothermal nucleic acid amplification test. J Clin Virol 2014; 61:81-86.
8. Wang J, Tai W, Angione SL et al. Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets. J Clin Microbiol 2013; 51:3324-3330.
9. Wu LT, Thomas I, Curran MD et al. Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol 2013; 51:3031-3038.
10. World Health Organization. Review of the 2013 influenza season in the southern hemisphere. Wkly Epidemiol Rec 2013; 88:509-520.
11. ® Influenza A & B System; Clinical Protocol Number 1319201. Scarborough, ME: Alere Scarborough Inc., 2013.
12. ® Influenza A+B FIA Package Insert. San Diego, CA: Quidel Corp, 2013.
13. ® Influenza A & B Card Package Insert. Scarborough, ME: Alere Scarborough Inc., 2013.
14. Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol 2010; 48:1425-1427.
15. ™ i Influenza A and B test. Available at http://www.alere.com/content/dam/alere/docs/australia/ID/Alere_i_US_release_6_16_2014.pdf (Accessed 26 September 2014).
16. ™ i Influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport medium. J Clin Microbiol 2014; 52:3992-3995.
17. Alere Scarborough, Inc. Alere i Influenza A & B Package Insert. Scarborough, ME: Alere Scarborough Inc., 2013.
18. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med 2009; 361:2493.
19. Chan MC, Lee N, Ngai KL, Leung TF, Chan PK. Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. J Clin Microbiol 2014; 52:497-501.
20. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS; Uyeki TM; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-24.
21. Taylor J, McPhie K, Druce J, Birch C, Dwyer DE. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses. J Med Virol 2009; 81:1918-1922.
22. Iovine NM, Ison T, Payton T, Morris JG Jr, Rand K. High percentage of false-positive results for influenza B obtained with a rapid influenza point-of-care test. Clin Infect Dis 2014; 59:604-605.
23. Ratnamohan VM, Taylor J, Zeng F et al. Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales, Australia. Virol J 2014; 11:113.
24. Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 2013; 7(Suppl 3):36-43.